BCKDK and neoplasm: Transfection of anti-BCKDK siRNA into non-small cell lung cancer cells, including A549, HCC827, and H1299, reduced the expression of BCKDK, decreased BCKDE1α phosphorylation, and inhibited the proliferation of tumor cells in these cancers.